Rchr
J-GLOBAL ID：200901003249562154
Update date: Apr. 03, 2023
Suzuki Yasuhiro
スズキ ヤスヒロ | Suzuki Yasuhiro
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Tokai University School of Medicine, Faculty of Medicine
About Tokai University School of Medicine, Faculty of Medicine
Search "Tokai University School of Medicine, Faculty of Medicine"
Detailed information
Research field (1)：
General surgery, pediatric surgery
Research keywords (8)：
臨床腫瘍学
, 大量化学療法
, 化学療法
, 温存手術
, 乳癌
, Breast conserving surgery
, Chemotherapy
, Breast cancer
Research theme for competitive and other funds (2)：
進行・再発乳がんに対する薬物療法
chemotherapy for metastatic breast cancer
Papers (4)：
Saiga R, Mizutani R, Inomoto C, Takekoshi S, Nakamura N, Tsuboi A, Osawa M, Arai M, Oshima K, Itokawa M, et al. Three-dimensional structure of brain tissue at submicrometer resolution. AIP Conference Proceedings. 2016. 1696
R. Mizutani, A. Takeuchi, K. Uesugi, S. Takekoshi, N. Nakamura, Y. Suzuki. Building Human Brain Network in 3D Coefficient Map Determined by X-ray Microtomography. 10TH INTERNATIONAL CONFERENCE ON X-RAY MICROSCOPY. 2011. 1365. 403-406
S Umemura, S Takekoshi, Y Suzuki, Y Saitoh, Y Tokuda, RY Osamura. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: Gene amplification does not contribute to EGFR expression. ONCOLOGY REPORTS. 2005. 14. 2. 337-343
Y Sekido, S Umemura, S Takekoshi, Y Suzuki, Y Tokuda, T Tajima, RY Osamura. Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation. INTERNATIONAL JOURNAL OF ONCOLOGY. 2003. 22. 6. 1225-1232
MISC (1)：
梅村しのぶ, 竹腰進, 日下部智美, 斉藤雄紀, 鈴木育宏, 徳田裕, 長村義之. ER陰性・HER2陰性乳癌における細胞増殖関連遺伝子発現について. 日本乳癌学会学術総会プログラム・抄録集. 2006. 14th. 243
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
